Wright Lassiter, CEO of the Henry Ford Health System in Detroit, joins “Squawk on the Street” to discuss how the hospital system is handling the influx of coronavirus patients. For access to live and exclusive video from CNBC subscribe to…
Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins “Squawk Box” to discuss whether there is merit to President Trump’s claims that he is now immune to the novel coronavirus after…
Former FDA commissioner Dr. Scott Gottlieb joins “Squawk Box” to discuss President Trump’s coronavirus diagnosis., experimental treatments and more. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Experts in the medical community have mixed opinions…
CNBC’s Eamon Javers joins ‘Closing Bell’ to report that President Trump has received a Regeneron antibody cocktail. Trump is currently working with a team of experts receiving recommendations after he tested positive for Covid-19. For access to live and exclusive…
Speaking with CNBC’s Brian Sullivan, Oxford Vaccine Group Co-Director Adrian Hill says the Covid-19 vaccine he is helping to develop with AstraZeneca is “more than likely” to work and expects to have millions of doses ready by the end of…
A potential coronavirus vaccine developed by Oxford University in the U.K. has produced a strong immune response in a large, early-stage human trial, according to newly-released data published Monday in the medical journal, The Lancet. CNBC’s Meg Tirrell reports. Subscribe…
